Furthermore, the oncogenic role proposed for METTL14 in BlCa was further supported by in vivo CAM assay, with significantly reduced tumor size and vessel density found in METTL14‐KD cells. This evidence concerns the gene METTL14 and bladder transitional cell carcinoma.